Naturland Holding ZrtBUD:NATURLAND 61 Interest Coverage is 60.50 as of Jun. 2025, which is 5% below its 10-year median of 63.70. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 685 Drug Manufacturers companies, Naturland Holding Zrt ranks better than 73.43% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Naturland Holding Zrt's
Operating Income
for the
six
months ended in Jun. 2025 was Ft1,053 Mil. Naturland Holding Zrt's Interest Expense for the
six
months ended in Jun. 2025 was Ft-17 Mil.
Naturland Holding Zrt's interest coverage for the quarter that ended in Jun. 2025 was 60.50.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Naturland Holding Zrt's Interest Coverage or its related term are showing as below:
BUD:NATURLAND'
s Interest Coverage Range Over the Past 10 Years
Min: 39 Med: 63.7 Max: No Debt
Current: 60.39
BUD:NATURLAND's Interest Coverage is ranked better than 73.43% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs BUD:NATURLAND: 60.39
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Naturland Holding Zrt Interest Coverage Related Terms
Naturland Holding Zrt Interest Coverage Historical Data
* Premium members only.
The historical data trend for Naturland Holding Zrt's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BUD:NATURLAND vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturland Holding Zrt Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Naturland Holding Zrt's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturland Holding Zrt (BUD:NATURLAND) has a Interest Coverage of 60.50 as of Jun. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Naturland Holding Zrt and its competitors. This is near median its historical median of 63.70. Over the past decade, Naturland Holding Zrt's Interest Coverage has ranged from 39.00 to 10,000.00. According to the industry distribution chart, Naturland Holding Zrt ranks #182 out of 685 companies in the Drug Manufacturers industry, placing it in the top 26.6%.
Is Naturland Holding Zrt's Interest Coverage too high?
Naturland Holding Zrt's current Interest Coverage of 60.50 is near median its 10-year median of 63.70. Over the past 10 years, this metric has ranged from a low of 39.00 to a high of 10,000.00. The Drug Manufacturers industry median Interest Coverage is 12.78. Naturland Holding Zrt's value of 60.50 is 373.4% above this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #182 out of 685 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #182 out of 685 companies for Interest Coverage. This puts Naturland Holding Zrt in the upper half of its industry. The industry median Interest Coverage is 12.78. Naturland Holding Zrt's value of 60.50 is 373.4% above this benchmark. Historically, Naturland Holding Zrt's own Interest Coverage has ranged from 39.00 to 10,000.00 over the past decade. While the company's 10-year median is 63.70 vs. the industry median of 12.78, Naturland Holding Zrt has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current Interest Coverage of 60.50 is 373.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current Interest Coverage is 60.50, which is near median its own 10-year median of 63.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current Interest Coverage is 60.50, which is near median its 10-year median of 63.70 and 373.4% above the Drug Manufacturers industry median of 12.78. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current Interest Coverage is 60.50 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?
Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued.
The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22.
GuruFocus considers Naturland Holding Zrt to be Fairly Valued.
Key valuation signals for BUD:NATURLAND:
Interest Coverage: 60.50 (near median its 10-year median of 63.70)
GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
Industry Position: 373.4% above the Drug Manufacturers median (#182 of 685)
No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score
Get the complete analysis for BUD:NATURLAND
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NATURLAND has been successfully added to your 
